Home/ Supplements/ Feverfew/ White Willow with Feverfew

White Willow with Feverfew

product on market Capsule Nature's Answer Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for White Willow with Feverfew
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

White Willow (Salix alba) bark extract
200 mg
Market median: 380.0mg (120 products) 8 studies — no high-quality reviews
White Willow
100 mg

Other Ingredients

Rice Flour Cellulose Calcium Silicate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take one (1) capsule twice a day with food or water.

Warnings & Precautions

Warning: Keep out of reach of children.

Do not use if safety seal is damaged or missing.

If you are pregnant, nursing, taking aspirin or other blood-thinning agents consult with your healthcare practitioner before use.

Discontinue 2 weeks prior to surgery, or if upset stomach occurs.

Formulation Notes

Salix alba/Tanacetum parthenium

Vegan

Additional Information

Store in a cool, dry place.

For product information, call (800) 439-2324.

Metadata

Product Details

UPC / SKU0 83000 16445 3
DSLD Entry Date2022-04-11
Product TypeBotanical
FormCapsule
DSLD ID264129
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

View all Feverfew products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.